obesity meds

Generic Semaglutide in 2026: Why So Many Patients Are Watching This Market

by
Generic Semaglutide in 2026: Why So Many Patients Are Watching This Market

Yes and no, and that is exactly why people are confused. In India, semaglutide generics are becoming real because Novo Nordisk’s patent on semaglutide expired there on March 20, 2026, opening the door for local drugmakers to launch lower-cost versions. Reuters reported approvals or launch plans from companies including Sun Pharma, Dr Reddy’s, and Zydus. … Read more

Weight Loss Drug Cost in 2026: What Patients Are Really Paying

by
Weight Loss Drug Cost in 2026: What Patients Are Really Paying

Because most people hear one number and think that is the real price. It usually is not. With GLP-1 drugs, the amount patients actually pay depends on whether they have insurance, whether obesity treatment is covered at all, which dose they need, and whether they qualify for a savings program. The ugly truth is that … Read more